Alenvir™

Tenofovir Alafenamide
Hepatitis Antivirals (Systemic Antiviral)

Indication:

Tenofovir Alafenamide is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease.

Dosage & Administration:

The recommended dosage of Tenofovir Alafenamide is 25 mg (one tablet) taken orally once daily with food.
No dosage adjustment is required in patients with mild, moderate, or severe renal impairment.Tenofovir Alafenamide is not recommended in patients with end stage renal disease (estimated creatinine clearance below J 5 mL/min).
No dosage adjustment is required in patients with mild hepatic impairment (Child-Pugh A). Tenofovir Alafenamide is not recommended in patients with decompensated (Child-Pugh B or C) hepatic impairment.

Preparation:

Each box contains blister strip of 10 tablets.